Team of Biotech professionals having expertise with Sequence listing standards
Our work is not DONE until you are 100% satisfied.
When it comes to innovations in biotechnology, the intricacies often involve genetic mutations, sequencing, and the manipulation of genes, whether by regulating, expressing, or silencing
The mysteries of genetic patenting just got easier with WIPO’s latest ST.26 Sequence Listing Standard. In the realm of patent applications involving nucleotide or amino
Every patent application that unveils nucleotide and/or amino acid sequences must adhere to international filing standards by including sequence listings. The imminent implementation of ST.26,
The World Intellectual Property Organization (WIPO) has introduced a new sequence listing standard, ST.26, which provides a uniform format for submitting nucleotide and/or amino acid
